Rezolute (RZLT) Change in Acquisitions & Divestments (2023 - 2026)
Rezolute recorded quarterly Change in Acquisitions & Divestments of $49.3 million in Q1 2026, down 0.8% quarter-over-quarter from $49.7 million in Q4 2025, and up 96.64% year-over-year from $25.1 million in Q1 2025.
Rezolute's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $49.3 million for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments rose 96.64% year-over-year to $49.3 million; the TTM figure through Mar 2026 stood at $147.2 million (up 27.85% YoY), while the FY2025 annual figure was $113.6 million, down 1.3% from the prior year.
- Change in Acquisitions & Divestments came in at $49.3 million for Q1 2026 at Rezolute, down from $49.7 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $49.7 million in Q4 2025 to a low of $18.6 million in Q3 2023.
- A 4-year average of $31.6 million and a median of $27.8 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments retreated 14.39% in 2025 and soared 96.64% in 2026, its largest moves.
- Rezolute's Change in Acquisitions & Divestments stood at $41.9 million in 2023, then slipped by 11.99% to $36.9 million in 2024, then jumped by 34.69% to $49.7 million in 2025, then slipped by 0.8% to $49.3 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $49.3 million, $49.7 million, and $20.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.30 Mn |
| Mar 31, 2026 | 49.30 Mn |
| Dec 31, 2025 | 49.70 Mn |
| Dec 31, 2025 | 49.70 Mn |
| Sep 30, 2025 | 20.40 Mn |
| Sep 30, 2025 | 20.40 Mn |
| Jun 30, 2025 | 27.80 Mn |
| Jun 30, 2025 | 27.80 Mn |
| Mar 31, 2025 | 25.07 Mn |
| Mar 31, 2025 | 25.07 Mn |
| Dec 31, 2024 | 36.90 Mn |
| Dec 31, 2024 | 36.90 Mn |
| Sep 30, 2024 | 23.83 Mn |
| Sep 30, 2024 | 23.83 Mn |
| Jun 30, 2024 | 29.33 Mn |
| Jun 30, 2024 | 29.33 Mn |
| Mar 31, 2024 | 25.24 Mn |
| Mar 31, 2024 | 25.24 Mn |
| Dec 31, 2023 | 41.93 Mn |
| Dec 31, 2023 | 41.93 Mn |
| Sep 30, 2023 | 18.60 Mn |
| Sep 30, 2023 | 18.60 Mn |